Tissue Diagnostics Market to reach US$6.358 billion by 2021

NOIDA, India - Nov. 18, 2016 - PRLog -- Knowledge Sourcing Intelligence announces the publication of a new report "Tissue Diagnostics Market - Forecasts from 2016 to 2021 " to their offering. The report has segmented the tissue diagnostics market by products (Instruments and Consumables), by technology ( ISH, IHC, Digital Pathology and Workflow Management and Special Staining), by end user (Hospitals Laboratories, Pharmaceutical Enterprises, Research Organizations, and Others), by disease (Breast Cancer, Gastric Cancer, Prostate Cancer, Lymphoma, Non-Small Cell Lung Cancer and Other Diseases  and by geography (Americas, Europe Middle East and Africa, and Asia Pacific). The report analyzes the global tissue diagnostics market which is anticipated to grow from US$3.682 billion in 2015 to US$6.358 billion by 2021, at a CAGR of 9.53% over the forecast period.

The market for tissue diagnostics has been significantly driven by continued lab automation and new cancer tests. Considerable growth in the number of new cancer cases and increased healthcare spending across emerging economies has strengthened the market. In recent years, the use of immunohistochemistry products as companion diagnostics devices is trending in the tissue diagnostic market.

Consumables to witness highest market growth in product type, while by technology, IHC will grow at a high rate during the projected period.

By product type, consumables are expected to witness highest market growth attributable to increasing partnerships among drug companies with diagnostic companies which will enable efficient production of effective drugs. Based on technology, immunohistochemistry (IHC) is projected to witness the highest growth owing to growing preference for this technology to detect chronic diseases.

Asia Pacific to witness the fastest regional market growth during projected period.

Asia- Pacific is expected to witness the highest growth in the years ahead given the high rate of technological adoption and robust research and development in emerging economies. Growing awareness regarding early diagnosis is another factor that is expected to drive the market considerably in both mature and nascent markets.

The key players of global tissue diagnostics market covered in this report include Abbott Laboratories, Bio SB, BioGenex, Agilent Technologies, Cell Signaling Technology, Sakura Finetek Japan, Hoffmann-La Roche Ltd, Danaher Corporation, Sigma-Aldrich Corporation, Thermo Fisher Scientific, Johnson & Johnson, Alere Inc., Siemens Healthcare and GE Healthcare

This report contains the market analysis on the current trends in the Tissue Diagnostics Market and the opportunities for the vendors over the next six years. It provides deep insights into the drivers and restraints of the industry. Tissue Diagnostics Market report also consists of in-depth regional analysis. A lot of statistically relevant tools and detailed industry analysis models such as scenario analysis have been used to forecast the market trends and forecasts up to the year 2021.

The report also talks about the strategies adopted by the industry leaders to gain an advantage over competitors and the recent deals that they have gone into to position themselves better in this market.

Purchase the complete report or request for a sample:

https://www.knowledge-sourcing.com/products/tissue-diagnostics-market-forecasts-from-2016-to-2021